SOX2 and lung cancer: Furthermore, the 3D organoid population treated with SM-3 showed a marked reduction in the levels of stem cell markers (CD44 and CD133) and stem cell transcription factors (SOX2 and OCT4) in lung cancer organoids (Fig. 9E, S3E, S4E).